ORMP
Price
$2.23
Change
+$0.01 (+0.45%)
Updated
Sep 5 closing price
Capitalization
91.44M
69 days until earnings call
SONN
Price
$2.85
Change
-$0.05 (-1.72%)
Updated
Sep 5 closing price
Capitalization
19.46M
Interact to see
Advertisement

ORMP vs SONN

Header iconORMP vs SONN Comparison
Open Charts ORMP vs SONNBanner chart's image
Oramed Pharmaceuticals
Price$2.23
Change+$0.01 (+0.45%)
Volume$58.88K
Capitalization91.44M
Sonnet BioTherapeutics Holdings
Price$2.85
Change-$0.05 (-1.72%)
Volume$348.24K
Capitalization19.46M
ORMP vs SONN Comparison Chart in %
Loading...
ORMP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SONN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ORMP vs. SONN commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ORMP is a StrongBuy and SONN is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 06, 2025
Stock price -- (ORMP: $2.23 vs. SONN: $2.85)
Brand notoriety: ORMP and SONN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ORMP: 83% vs. SONN: 6%
Market capitalization -- ORMP: $91.44M vs. SONN: $19.46M
ORMP [@Biotechnology] is valued at $91.44M. SONN’s [@Biotechnology] market capitalization is $19.46M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.56B to $0. The average market capitalization across the [@Biotechnology] industry is $1.91B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ORMP’s FA Score shows that 0 FA rating(s) are green whileSONN’s FA Score has 0 green FA rating(s).

  • ORMP’s FA Score: 0 green, 5 red.
  • SONN’s FA Score: 0 green, 5 red.
According to our system of comparison, ORMP is a better buy in the long-term than SONN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ORMP’s TA Score shows that 5 TA indicator(s) are bullish while SONN’s TA Score has 3 bullish TA indicator(s).

  • ORMP’s TA Score: 5 bullish, 3 bearish.
  • SONN’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, ORMP is a better buy in the short-term than SONN.

Price Growth

ORMP (@Biotechnology) experienced а +1.36% price change this week, while SONN (@Biotechnology) price change was -12.31% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.52%. For the same industry, the average monthly price growth was +14.52%, and the average quarterly price growth was +33.01%.

Reported Earning Dates

ORMP is expected to report earnings on Nov 14, 2025.

Industries' Descriptions

@Biotechnology (+2.52% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ORMP($91.4M) has a higher market cap than SONN($19.5M). ORMP has higher P/E ratio than SONN: ORMP (20.91) vs SONN (0.29). SONN YTD gains are higher at: 95.205 vs. ORMP (-7.851). SONN has higher annual earnings (EBITDA): -13.97M vs. ORMP (-22.07M). ORMP has more cash in the bank: 97.9M vs. SONN (321K). SONN has less debt than ORMP: SONN (68.8K) vs ORMP (912K). ORMP has higher revenues than SONN: ORMP (2M) vs SONN (1M).
ORMPSONNORMP / SONN
Capitalization91.4M19.5M469%
EBITDA-22.07M-13.97M158%
Gain YTD-7.85195.205-8%
P/E Ratio20.910.297,254%
Revenue2M1M200%
Total Cash97.9M321K30,498%
Total Debt912K68.8K1,326%
FUNDAMENTALS RATINGS
ORMP vs SONN: Fundamental Ratings
ORMP
SONN
OUTLOOK RATING
1..100
1664
VALUATION
overvalued / fair valued / undervalued
1..100
53
Fair valued
82
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
95100
PRICE GROWTH RATING
1..100
5937
P/E GROWTH RATING
1..100
4796
SEASONALITY SCORE
1..100
n/a36

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ORMP's Valuation (53) in the Pharmaceuticals Other industry is in the same range as SONN (82) in the null industry. This means that ORMP’s stock grew similarly to SONN’s over the last 12 months.

ORMP's Profit vs Risk Rating (100) in the Pharmaceuticals Other industry is in the same range as SONN (100) in the null industry. This means that ORMP’s stock grew similarly to SONN’s over the last 12 months.

ORMP's SMR Rating (95) in the Pharmaceuticals Other industry is in the same range as SONN (100) in the null industry. This means that ORMP’s stock grew similarly to SONN’s over the last 12 months.

SONN's Price Growth Rating (37) in the null industry is in the same range as ORMP (59) in the Pharmaceuticals Other industry. This means that SONN’s stock grew similarly to ORMP’s over the last 12 months.

ORMP's P/E Growth Rating (47) in the Pharmaceuticals Other industry is somewhat better than the same rating for SONN (96) in the null industry. This means that ORMP’s stock grew somewhat faster than SONN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ORMPSONN
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 1 day ago
76%
Bullish Trend 1 day ago
76%
Momentum
ODDS (%)
Bullish Trend 1 day ago
79%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bullish Trend 1 day ago
76%
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
80%
Bearish Trend 1 day ago
90%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
73%
Advances
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 12 days ago
79%
Declines
ODDS (%)
N/A
Bearish Trend 1 day ago
90%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
86%
Bullish Trend 1 day ago
82%
Aroon
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
89%
View a ticker or compare two or three
Interact to see
Advertisement
ORMP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SONN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SPCE3.220.14
+4.55%
Virgin Galactic Holdings
GREE1.180.05
+4.42%
Greenidge Generation Holdings
DAKT17.38-0.06
-0.34%
Daktronics
TNL62.69-0.76
-1.20%
Travel + Leisure Co
KDP28.65-0.60
-2.05%
Keurig Dr Pepper

ORMP and

Correlation & Price change

A.I.dvisor tells us that ORMP and VALN have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ORMP and VALN's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ORMP
1D Price
Change %
ORMP100%
+0.45%
VALN - ORMP
29%
Poorly correlated
-2.15%
FULC - ORMP
28%
Poorly correlated
+11.34%
BCAB - ORMP
28%
Poorly correlated
+7.54%
PRLD - ORMP
27%
Poorly correlated
+7.89%
SONN - ORMP
27%
Poorly correlated
-1.72%
More